Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis.
Active, not recruitingOBSERVATIONAL
Enrollment
70
Participants
Timeline
Start Date
June 20, 2025
Primary Completion Date
September 1, 2025
Study Completion Date
December 30, 2025
Conditions
Amyloidosis in Transthyretin (TTR)Hereditary Amyloidosis, Transthyretin-Related
Trial Locations (1)
1752
HGNPE, Buenos Aires
All Listed Sponsors
lead
Hospital General de Niños Pedro de Elizalde
OTHER
NCT07080268 - Validation of a Questionnaire for Quality of Life Assessment in Patients With Transthyretin Amyloidosis. | Biotech Hunter | Biotech Hunter